eadaily

The star of the Russian chanson refused to celebrate her birthday during SMO

Singer Lyubov Uspenskaya has not celebrated her birthday and other holidays for four years. She told Channel Five about this. After the start of the special military operation, Uspenskaya decided not ...
Pharmabiz

VectorY Therapeutics doses first participant in phase 1/2 PIONEER-ALS trial to evaluate VTx-002 in people with amyotrophic lateral sclerosis

VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced that the first participant has been dosed in its phase 1/2 PIONEER-ALS trial evaluating ...
PharmiWeb

VectorY Therapeutics Announces First Participant Dosed in Phase 1/2 PIONEER-ALS Clinical Trial of VTx-002 in People with Amyotrophic Lateral Sclerosis (ALS)

VTx-002 is a first-in-class vectorized antibody to holistically target TDP-43 pathology in ALS recently granted FDA Fast Track Designation for expedited review Amsterdam, The Netherlands, and Boston, ...
ALS News Today

First ALS patient dosed in study of experimental gene therapy VTx-002

VTx-002 is an experimental gene therapy for ALS that has FDA fast-track designation. It targets toxic TDP-43 protein aggregates, a key driver of ALS progression. The therapy is in a Phase 1/2 clinical ...
Business Wire

VectorY Therapeutics Announces First Participant Dosed in Phase 1/2 PIONEER-ALS Clinical Trial of VTx-002 in People with Amyotrophic Lateral Sclerosis (ALS)

AMSTERDAM & BOSTON--(BUSINESS WIRE)--VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the first participant has been dosed in its ...